| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 6.046 | 17.929 | 39.961 | 46.912 | 53.918 |
| Total Income - EUR | - | - | - | - | - | 6.046 | 17.929 | 39.961 | 46.912 | 53.918 |
| Total Expenses - EUR | - | - | - | - | - | 3.282 | 5.629 | 10.651 | 18.192 | 18.725 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.764 | 12.300 | 29.310 | 28.720 | 35.193 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.583 | 11.773 | 28.409 | 28.260 | 34.665 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Freeatlast Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 786 | 512 | 997 | 492 | 1.433 |
| Current Assets | - | - | - | - | - | 2.592 | 11.323 | 33.140 | 29.637 | 34.907 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 10.980 | 25.517 | 26.576 | 31.488 |
| Cash | - | - | - | - | - | 2.592 | 343 | 7.623 | 3.061 | 3.419 |
| Shareholders Funds | - | - | - | - | - | 2.583 | 11.773 | 33.810 | 28.260 | 34.665 |
| Social Capital | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | 795 | 62 | 327 | 1.869 | 1.675 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Freeatlast Therapy S.r.l.